Vanderbilt Center for Antibody Therapeutics (VCAT)
-
May 16, 2013
Grant targets new therapies for Ebola, Marburg viruses
Vanderbilt’s James Crowe Jr., M.D., and a collaborator in Texas have been awarded a $4.4 million grant from the U.S. Department of Defense to study new ways to treat and prevent Ebola and Marburg viruses. -
April 4, 2013
Symposium to offer look at latest infectious diseases imaging research
The latest research on imaging infectious diseases will be discussed during a mini-symposium noon to 5 p.m., April 12, at the Vanderbilt Student Life Center Board of Trust Room. -
February 21, 2013
Structural snapshot hints at new influenza approach
A careful look at how the body’s natural defenses disarm virulent strains of influenza hints at the possibility of a way to fight the flu. -
January 17, 2013
Awards honor research staff’s critical role in discovery
Karen Adkins, R.N., Elizabeth Card, R.N., and Frances Smith-House are the recipients of the 2012 Research Staff Awards at Vanderbilt University Medical Center. -
December 6, 2012
Repository samples help shape view of new rhinovirus
Vanderbilt researchers used a treasure trove of samples collected and stored at the Vanderbilt Vaccine Clinic (VVC) to prove a particular human rhinovirus (HRV), has been causing more than just the common cold for decades. -
November 1, 2012
Genomic research gains ad-“vantage” with new resources
Vanderbilt University Medical Center has stepped up its support of research aimed at cracking the mysteries of the genome, the master DNA code. -
July 19, 2012
Long antibodies better against HIV
Understanding how antibodies with long “loops” form may be important for HIV vaccine development.